Susquehanna International Group’s OptimizeRx OPRX Stock Holding History
Bought
Maintained
Sold
Other funds holding OPRX
WCA
RA
PHP
VCM
KCM
RHJA
Susquehanna International Group's OPRX Position: Q1 2026 in Review
Susquehanna International Group reduced its OptimizeRx (OPRX) stake by 62% in Q1 2026, selling an estimated $171K and leaving 11,373 shares worth $71.4K. The position accounts for ﹤0.01% of the portfolio, ranked #12500.
Susquehanna International Group first reported a position in OPRX in Q4 2018 and has held it in 16 quarters since. The position peaked at $2.95M in Q1 2023. 127 funds tracked by Wall St. Rank hold OPRX as of Q1 2026.
- Susquehanna International Group held 11,373 shares of OptimizeRx worth $71.4K as of Q1 2026.
- Susquehanna International Group sold 18,368 OptimizeRx shares in Q1 2026, an estimated $171K.
- OptimizeRx made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #12500 holding.
- Susquehanna International Group first reported a position in OptimizeRx in Q4 2018 and has held it in 16 quarters since.
- Susquehanna International Group's OptimizeRx position peaked at $2.95M in Q1 2023.
- 127 funds tracked by Wall St. Rank held OptimizeRx as of Q1 2026.
Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.